Saturday, 31 October 2026European Markets

AKER HORIZONS Stock Was Up By 15.16% On Tuesday

Loading stream...

(VIANEWS) - The Market ended the session with AKER HORIZONS (AKH.OL) jumping 15.16% to kr3.57 on Tuesday while Oslo Børs Benchmark Index_GI rose 1.1% to kr1,342.78.

AKER HORIZONS's last close was kr3.10, 82.84% below its 52-week high of kr18.07.

About AKER HORIZONS

Aker Horizons ASA, through its subsidiaries, develops and invests in a portfolio of companies in the renewable energy and green technology comprising private and public companies worldwide. It sources, develops, structures, builds, and operates wind and solar power assets; and develops, builds, owns, and operates clean hydrogen production at industrial scale. The company also provides products, technology, and solutions within the field of carbon capture, utilization, and storage. In addition, it offers products and services to the hydropower industry; designs and delivers superconducting systems; and produces silicon materials. The company was incorporated in 2020 and is headquartered in Lysaker, Norway. Aker Horizons ASA operates as a subsidiary of Aker Capital AS.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-6.49.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -81.14%.

Volume

Today's last reported volume for AKER HORIZONS is 9617650 which is 297.54% above its average volume of 2419270.

Volatility

AKER HORIZONS's last week, last month's, and last quarter's current intraday variation average was a negative 1.03%, a negative 1.20%, and a positive 2.62%.

AKER HORIZONS's highest amplitude of average volatility was 1.03% (last week), 2.51% (last month), and 2.62% (last quarter).

Yearly Top and Bottom Value

AKER HORIZONS's stock is valued at kr3.57 at 22:31 EST, way under its 52-week low of kr5.12.

Revenue Growth

Year-on-year quarterly revenue growth grew by 60.8%, now sitting on 3B for the twelve trailing months.

More news about AKER HORIZONS (AKH.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com